D3 Bio Investigative Site is a clinical research site located in Stanford, California, United States 94305.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
D3 Bio Investigative Site has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: HER-2 Positive Advanced Solid Tumors.
Sponsors: D3 Bio (Wuxi) Co., Ltd.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
D3 Bio Investigative Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
D3 Bio Investigative Site has 1 clinical trials on record, with 1 currently active. Their work covers HER-2 Positive Advanced Solid Tumors.
D3 Bio Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.